Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Circumpolar Health|October 28, 2011
Innovations in health service organization and delivery in northern rural and remote regions: a review of the literatureCraig Mitton, Francois Dionne, Lisa Masucci, et al.
Healthcare Management Forum|February 20, 2010
How to control the costs of health care services--an inventory of strategic optionsFrancois Dionne, Craig Mitton, Jean Shoveller, et al.
BMC Health Services Research|July 16, 2011
Difficult decisions in times of constraint: criteria based resource allocation in the Vancouver Coastal Health AuthorityCraig Mitton, Francois Dionne, Rizwan Damji, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 25, 2013
Allocating limited resources in a time of fiscal constraints: a priority setting case study from Dalhousie University Faculty of MedicineCraig Mitton, Adrian Levy, Diane Gorsky, et al.
Open Forum Infectious Diseases|June 27, 2024
A Geographically Weighted Cost-effectiveness Analysis of Newborn Cytomegalovirus ScreeningPaul M Lantos, Soren Gantt, Mark Janko, et al.
Pediatric Blood & Cancer|December 23, 2017
An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclinesFrancois Dionne, Folefac Aminkeng, Amit P Bhavsar, et al.
JAMA Pediatrics|October 11, 2016
Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus InfectionSoren Gantt, Francois Dionne, Fred K Kozak, et al.
Global Spine Journal|November 18, 2025
Developing a Lifetime Cost Calculator for Spinal Cord Injury: The SCI Cost CalculatorCraig Mitton, Francois Dionne, Sydney Heschuk, et al.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) CollaborationPam Takhar, Marc Geirnaert, Scott Gavura, et al.
Pageof 3